Today, the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF) have awarded the ESCEO-IOF Pierre Delmas Medal to Professor Claudia Campusano, MD, MSc., Professor of Medicine and Endocrinology at the Faculty of Medicine, Universidad de los Andes in Santiago, Chile. 

The ESCEO-IOF Pierre Delmas Medal was presented at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, taking place in London, UK from April 11 to 14, 2024. The award recognizes a researcher who has made outstanding and major scientific contributions to the study of bone and mineral diseases. It is named after the late Professor Pierre Delmas, Co-Founder and First President of IOF who was Professor of Medicine and Rheumatology at the University of Lyon, France, Director of the INSERM research unit ‘Pathophysiology of Osteoporosis’. Professor Delmas was an outstanding scientist who directed essential basic and clinical research in metabolic bone diseases, particularly in osteoporosis and osteoarthritis.

The Award was presented by IOF President Professor Nicholas Harvey and ESCEO President Professor Jean-Yves Reginster, who stated.

“ESCEO and IOF are honoured to present this prestigious Award to Professor Claudia Campusano in recognition of her outstanding contributions to clinical research in metabolic bone diseases and influential work as an educator both in the academic setting and in patient outreach. We also extend our appreciation for her enduring and engaged involvement in IOF to which she has contributed significantly as a Board member since 2015, and as a member of the Regional Advisory Council for Latin America. Her valued collaboration in educational, research and policy initiatives such as, most recently, the IOF LATAM Audit, has been instrumental in raising awareness and promoting public health policies for the betterment of patients in the region.”

Professor Campusano is an endocrinologist and Professor of Medicine and Endocrinology at the Faculty of Medicine, Universidad de los Andes, Santiago, Chile. She is an active member of several medical societies including Sociedad Médica de Santiago, Sociedad Chilena de Endocrinologia y Diabetes (Vice-President 2023-2024 and the next president), Sociedad Chilena de Osteologia y Metabolismo Mineral (Past President 2006-2007)
Professor Campusano has been a Board member of the IOF since 2015 and is a member of the IOF Regional Advisory Council for Latin America. Her major interests are related to education and clinical investigation of metabolic bone diseases, particularly osteoporosis and vitamin D.  She has published more than 60 scientific articles and book chapters related to calcium, vitamin D and bone metabolism. 

Professor Campusano stated, “It is a great honour to receive this Award. It gives me further inspiration to continue my work and collaborations with colleagues across the region and at the global level to improve the lives of people with osteoporosis worldwide.”


About the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO)
Held jointly by IOF and ESCEO, the WCO-IOF-ESCEO annual congress is the world’s largest forum for the presentation of clinical research and new advances in the prevention and management of musculoskeletal disorders, including osteoporosis, osteoarthritis, sarcopenia, and frailty. The WCO-IOF-ESCEO 2024 is being held from April 11-14, 2024 in London, UK. For complete information visit    
The next WCO-IOF-ESCO is planned from April 10-13, 2025 in Rome, Italy.  

The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policymakers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception.

About IOF
The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers as well as more than 330 patient, medical and research organizations, work together to make fracture prevention and healthy mobility a worldwide healthcare priority.  @iofbonehealth